Strong expression of EZH2 and H3K27me3 is associated with poor survival time in small cell lung cancer

Fernandes AP, Alves RDS, Watte G, Kunze P, Roehe AV, Schneider-Stock R (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Cancer Research American Association for Cancer Research

Publisher: AMER ASSOC CANCER RESEARCH

City/Town: PHILADELPHIA

Conference Proceedings Title: CANCER RESEARCH

Event location: Atlanta, GA

DOI: 10.1158/1538-7445.AM2019-3713

Authors with CRIS profile

Philipp Kunze Institute of Pathology Regine Schneider-Stock Professur für Experimentelle Tumorpathologie

Involved external institutions

Universidade Federal de Ciências da Saúde de Porto Alegre BR Brazil (BR) Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS) BR Brazil (BR)

How to cite

APA:

Fernandes, A.P., Alves, R.D.S., Watte, G., Kunze, P., Roehe, A.V., & Schneider-Stock, R. (2019). Strong expression of EZH2 and H3K27me3 is associated with poor survival time in small cell lung cancer. In CANCER RESEARCH. Atlanta, GA: PHILADELPHIA: AMER ASSOC CANCER RESEARCH.

MLA:

Fernandes, Ana Paula, et al. "Strong expression of EZH2 and H3K27me3 is associated with poor survival time in small cell lung cancer." Proceedings of the Annual Meeting of the American-Association-for-Cancer-Research (AACR), Atlanta, GA PHILADELPHIA: AMER ASSOC CANCER RESEARCH, 2019.

BibTeX: Download